Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.

Koenigs MB, Lefranc-Torres A, Bonilla-Velez J, Patel KB, Hayes DN, Glomski K, Busse PM, Chan AW, Clark JR, Deschler DG, Emerick KS, Hammon RJ, Wirth LJ, Lin DT, Mroz EA, Faquin WC, Rocco JW.

J Natl Cancer Inst. 2019 Sep 1;111(9):933-942. doi: 10.1093/jnci/djy224.

PMID:
30715409
2.

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.

Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS, Deschler DG, Varvares MA, Mylvaganam R, Rozenblatt-Rosen O, Rocco JW, Faquin WC, Lin DT, Regev A, Bernstein BE.

Cell. 2017 Dec 14;171(7):1611-1624.e24. doi: 10.1016/j.cell.2017.10.044. Epub 2017 Nov 30.

3.

Intra-tumor heterogeneity in head and neck cancer and its clinical implications.

Mroz EA, Rocco JW.

World J Otorhinolaryngol Head Neck Surg. 2016 Jun;2(2):60-67. doi: 10.1016/j.wjorl.2016.05.007. Epub 2016 Jul 22.

4.

The challenges of tumor genetic diversity.

Mroz EA, Rocco JW.

Cancer. 2017 May 15;123(6):917-927. doi: 10.1002/cncr.30430. Epub 2016 Nov 8. Review.

5.

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.

Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, Isakoff S, Ellisen LW, Bardia A.

J Clin Oncol. 2015 Nov 1;33(31):3621-7. doi: 10.1200/JCO.2015.62.2126. Epub 2015 Sep 14.

6.
7.

Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Bonilla-Velez J, Mroz EA, Hammon RJ, Rocco JW.

Otolaryngol Clin North Am. 2013 Aug;46(4):521-43. doi: 10.1016/j.otc.2013.04.009. Epub 2013 Jun 27. Review.

8.

High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.

Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW.

Cancer. 2013 Aug 15;119(16):3034-42. doi: 10.1002/cncr.28150. Epub 2013 May 20.

9.

MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.

Mroz EA, Rocco JW.

Oral Oncol. 2013 Mar;49(3):211-5. doi: 10.1016/j.oraloncology.2012.09.007. Epub 2012 Oct 15.

10.

Gene expression analysis as a tool in early-stage oral cancer management.

Mroz EA, Rocco JW.

J Clin Oncol. 2012 Nov 20;30(33):4053-5. doi: 10.1200/JCO.2012.44.8050. Epub 2012 Oct 8. No abstract available.

11.

Implications of the oropharyngeal cancer epidemic.

Mroz EA, Forastiere AA, Rocco JW.

J Clin Oncol. 2011 Nov 10;29(32):4222-3. doi: 10.1200/JCO.2011.37.8893. Epub 2011 Oct 3. No abstract available.

12.

Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.

Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW.

Clin Cancer Res. 2010 Apr 1;16(7):2138-46. doi: 10.1158/1078-0432.CCR-09-3185. Epub 2010 Mar 16.

13.

Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.

Mroz EA, Rocco JW.

J Clin Oncol. 2010 Feb 10;28(5):715-7. doi: 10.1200/JCO.2009.26.3475. Epub 2010 Jan 4. No abstract available.

PMID:
20048171
14.

Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.

Michaud WA, Nichols AC, Mroz EA, Faquin WC, Clark JR, Begum S, Westra WH, Wada H, Busse PM, Ellisen LW, Rocco JW.

Clin Cancer Res. 2009 Mar 1;15(5):1645-54. doi: 10.1158/1078-0432.CCR-08-2581. Epub 2009 Feb 24.

15.

HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.

Nichols AC, Faquin WC, Westra WH, Mroz EA, Begum S, Clark JR, Rocco JW.

Otolaryngol Head Neck Surg. 2009 Feb;140(2):228-34. doi: 10.1016/j.otohns.2008.11.025.

PMID:
19201294
16.

COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells.

Mroz EA, Baird AH, Michaud WA, Rocco JW.

Cancer Res. 2008 Aug 1;68(15):6049-53. doi: 10.1158/0008-5472.CAN-08-1279.

17.

RNA interference: natural, experimental, and clinical roles in cancer biology.

Mroz EA, Rocco JW.

Head Neck. 2006 Dec;28(12):1132-41. Review.

PMID:
16823868
19.
20.

Calcium and magnesium transport by isolated goldfish hair cells.

Mroz EA, Lechene C.

Hear Res. 1993 Nov;70(2):139-45.

PMID:
8294257
21.

Flavin adenine dinucleotide is a major endogenous fluorophore in the inner ear.

Sewell WF, Mroz EA.

Hear Res. 1993 Nov;70(2):131-8.

PMID:
7904988
22.

Rapid resting ion fluxes in goldfish hair cells are balanced by (Na+,K+)-ATPase.

Mroz EA, Nissim KR, Lechene C.

Hear Res. 1993 Oct;70(1):22-30.

PMID:
8276730
23.
24.
25.

Possible role of carbamates in neurotoxicity and neurotransmitter inactivation.

Mroz EA.

Science. 1989 Mar 24;243(4898):1615. No abstract available.

PMID:
2564700
26.

Pharmacological alterations of the activity of afferent fibers innervating hair cells.

Mroz EA, Sewell WF.

Hear Res. 1989 Mar;38(1-2):141-62.

PMID:
2565327
27.

A possible neurotransmitter role for CGRP in a hair-cell sensory organ.

Adams JC, Mroz EA, Sewell WF.

Brain Res. 1987 Sep 1;419(1-2):347-51.

PMID:
2890408
28.

Neuroactive substances in inner ear extracts.

Sewell WF, Mroz EA.

J Neurosci. 1987 Aug;7(8):2465-75.

29.

Isolation and culture of auditory cells from the goldfish (Carassius auratus).

Sweeney TK, Mroz EA, Sewell WF.

Hear Res. 1987;28(2-3):153-60.

PMID:
3308802
30.

Pancreatic zymogen granules differ markedly in protein composition.

Mroz EA, Lechene C.

Science. 1986 May 16;232(4752):871-3.

PMID:
2422756
31.

Nucleotides in a single mammalian ovum or preimplantation embryo.

Leese HJ, Biggers JD, Mroz EA, Lechene C.

Anal Biochem. 1984 Aug 1;140(2):443-8.

PMID:
6486431
32.

An NADH-coupled assay for femtogram or nanogram quantities of chymotrypsin.

Mroz EA, Lechene C.

Anal Biochem. 1983 Jan;128(1):181-5.

PMID:
6846791
33.

Fluorescence assay for picomole quantities of ammonia.

Mroz EA, Roman RJ, Lechene C.

Kidney Int. 1982 Mar;21(3):524-7. No abstract available.

34.

Fluorescence analysis of picoliter samples.

Mroz EA, Lechene C.

Anal Biochem. 1980 Feb;102(1):90-6. No abstract available.

PMID:
7356167
35.

Delayed iontophoretic ejection of substance P from glass micropipettes: correlation with time-course of neuronal excitation in vivo.

Guyenet PG, Mroz EA, Aghajanian GK, Leeman SE.

Neuropharmacology. 1979 Jun;18(6):553-8. No abstract available.

PMID:
481708
36.

Descending substance P-containing pathway: a component of the ansa lenticularis.

Palkovits M, Mroz EA, Brownstein MJ, Leeman SE.

Brain Res. 1978 Nov 3;156(1):124-8. No abstract available.

PMID:
308833
37.

On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.

Brownstein MJ, Mroz EA, Tappaz ML, Leeman SE.

Brain Res. 1977 Oct 28;135(2):315-23.

PMID:
922480
38.

Evidence for substance P in the striato-nigral tract.

Mroz EA, Brownstein MJ, Leeman SE.

Brain Res. 1977 Apr 15;125(2):305-11.

PMID:
856411
39.

Substance P.

Mroz EA, Leeman SE.

Vitam Horm. 1977;35:209-81. Review. No abstract available.

PMID:
343362
40.

Release of substance P from isolated nerve endings.

Schenker C, Mroz EA, Leeman SE.

Nature. 1976 Dec 23-30;264(5588):790-2. No abstract available.

PMID:
13307
41.

Regional distribution of substance P in the brain of the rat.

Brownstein MJ, Mroz EA, Kizer JS, Palkovits M, Leeman SE.

Brain Res. 1976 Nov 5;116(2):299-305.

PMID:
974776
42.
43.

Substance P.

Leeman SE, Mroz EA.

Life Sci. 1974 Dec 15;15(12):2033-44. Review. No abstract available.

PMID:
4621245
44.

Electronic calibration for indocyanine dye-dilution curves.

Sullivan FJ, Mroz EA Jr, Miller RE.

Am Heart J. 1973 Apr;85(4):506-10. No abstract available.

PMID:
4570071

Supplemental Content

Support Center